Virogates
6.5 DKK -11.92%Be the first to follow this company
Virogates is a medical technology company. Business operations are conducted within the research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis, and further treatment of diseases, mainly cardiovascular diseases, cancer, and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Revenue
5.58M
EBIT %
-225.27 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Denmark
VIRO
Daily low / high price
6.5 / 7.32
DKK
Market cap
41.91M DKK
Turnover
2.77K DKK
Volume
424
Latest videos
Financial calendar
Interim report
02.05.2024
Interim report
15.08.2024
Interim report
07.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
N.P. Louis-Hansen APS. | 25.8 % | 25.8 % |
Kim Ginnerup APS | 10.3 % | 10.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA
ViroGates gives notice to convene the Annual General Meeting on 25 April 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools